BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies. BioMed X announced today...
BioMed X Launches a New Call for Application in Autoimmune Disease Research
A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease. BioMed X, an...